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Prokaryotic expression system is the most widely used host for the production of recombinant 
proteins but inclusion body formation is a major bottleneck in the production of recombinant proteins 
in prokaryotic cells, especially in Escherichia coli. In vitro refolding of inclusion body into the the 
proteins with native conformations is a solution for this problem but there is a need for optimization of 
condition for each protein specifically. Several approaches have been described for in vitro refolding; 
most of them involve the use of additives for assisting correct refolding. Co-solutes play a major role 
in refolding process and can be classified according to their function as, aggregation suppressors and 
folding enhancers. This study presents a review of additives that are used in refolding process of 
insoluble recombinant proteins in small scale and industrial process.  
 





Recombinant expression of proteins is an essential 
method for producing target proteins and one of the most 
important unit processes for the production of therapeutic 
protein and structural study (Clark, 2001; Middelberg, 
2002; Tsumoto et al., 2003; Salehi et al., 2010). There 
are different expression systems for producing recom-
binant proteins in biotechnology industry. Expression in 
mammalian cells produces active recombinant proteins 
that have post translation modification but expression by 
this system is time consuming and expensive. E. coli 
bacteria still represent a convenient expression system 
that is used for the production of many recombinant 
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Abbreviations: rPA, Recombinant plasminogen activator; IB, 
inclusion body; Gn-HCl, guanidine hydrochloride; 2-ME, 2-
mercaptoethanol; PMSF, phenylmethylsulfonyl fluoride; BSA, 
bovine serum albumin; DTT, dithiothreitol; SDS-PAGE, sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis. 
result in their accumulation as insoluble aggregates, 
proteins expressed in prokaryotic hosts undergo 
misfolding or incomplete folding processes that usually 
which are called inclusion bodies (Kafshnochi et al., 
2010). In vitro refolding is required for obtaining active 
protein from inclusion body aggregates which consist of 
four main steps (Figure 1): Inclusion body isolation, 
solubilization, refolding and purification. Because of high 
density of IBs, they are separated easily by centrifuge. 
After isolation of the IBs, the proteins contained in the 
inclusion bodies need to be solubilized, usually by high 
concentration of denaturing agents such as urea or 
guanidine HCl (Gn-HCl). Then, solubilized IBs are 
subjected to refolding in specified conditions. Refolding of 
proteins from inclusion bodies is influenced by different 
factors including solubilization method, removal of the 
denaturant, and assistance of refolding by co-solute or 
additives. The refolding condition is critical in order to 
obtain acceptable amounts of active protein. It has been 
known that additives, especially low molecular weight 
compounds may significantly enhance the yield of the 
refolding process. In many cases, inclusion body protein 
can only be successfully refolded by making use of  these  














FOLDING ADDITIVES  
 
Low  molecular  weight  additives  are  usually  added  for  
refolding buffer to promote the refolding process. In the 
case of refolding by dilution, there is a residual 
concentration of guanidine HCl or urea in refolding buffer. 
This low concentration of denaturants leads to the 
sustaining folding intermediates in soluble and flexible 
state, thus refolding yield efficiency improves. In addition 
to residual concentration of denaturants, additives should 
be applied for refolding buffer to decrease the degree of 
aggregates and misfolds. Co-solute may be classified 
into two groups: folding enhancer and aggregation 
suppressor. In principle, folding enhancer enhances 
protein-protein interaction, while aggregation suppressor 
reduces side chain interactions (Tsumoto et al., 2003; 





The folding enhancers faciliate the interaction between 
proteins and thus increase the stability of proteins, 
whereas aggregation suppressor reduces side chain 
interaction of folding intermediates without interfering with 
refolding process (Tsumoto et al., 2003). Common 
additives used in refolding of recombinant proteins are 





Urea, guanidine HCl, and strong ionic detergents are  
solubilizing agents that are most frequently used for initial 
solubilization of inclusion bodies. High concentration of 
denaturants unfolds almost all kind of proteins. Among 
denaturants, ionic detergents are the strongest 
denaturants in dispersing IBs into monomolecular 
structure due to strong electrostatic repulsion of 
detergent/protein complexes (Tsumoto et al., 2003), but 
removal of detergents from proteins is problematic in 
most cases. Therefore, high concentration of chaotropic 
denaturants such as urea and guanidine HCl is still the 
most used denaturants in solubilization processes.The 
proteins that are difficult to refold have also been 
successfully refolded in the presence of non-denaturing 
concentrations of denaturant (Jaenicke and Rudolph, 





Arginine is one of the most useful reagents that are 
effective in assisting refolding of recombinant proteins 
from inclusion bodies. It is an aggregation suppressor 
that improves refolding yield; however, the mechanism of 
arginine action during refolding is still unclear. Arginine 
was first used in refolding of human tissue type 
plasminogen activator (Buchner and Rudolph, 1991; 
Rudolph and Fischer, 1990). Since then, it has been used 
for refolding of a variety of proteins including casein 
kinase II, (Lin and Traugh, 1993), Fab antibody fragments 
(Buchner et al., 1992; Buchner and Rudolph, 1991), 
growth hormone (Hsih et al., 1997), human gamma 
interferon (Arora and Khanna, 1996), human matrix 
metalloproteinase-7human neurotrophins (Rattenholl et 
al., 2001) human p53 tumor suppressor protein (Bell et 
al., 2002), interleukin-21 (Asano et al., 2002),  interleukin-


















































6 receptor (Oneda and Inouye, 1999), lysozyme 
(Havehan and Clark, 1997), single-chain Fv fragments 
(Tsumoto et al., 1998) and single-chain immunotoxins  
 (Brinkmann et al., 1992; Buchner and Rudolph, 1991). 
However, arginine may acts as a protein-denaturant, 
which limits the expansion of its applications. It was 
shown that the activity and stability of certain enzymes 
were perturbed by arginine and arginine is a protein-
destabilizer (Yancey et al., 1982). Xie et al. (2007) have 
made a similar observation and showed that fluorescence 
properties of aminoacylase are perturbed by arginine. 
They interpreted the observed effects of arginine in terms 
of denaturing property of the guanidinium group, which 
makes guanidine hydrochloride (Gn-HCl) a strong 
denaturant. But arginine differs from Gn-HCl in the mode 





Cyclodextrins have been reported to suppress aggregate 
formation during the refolding of recombinant proteins. 
These cyclic glucose macromolecules have hydrophobic 
cavities and functional groups that can interact with 
polypeptide chains by weak forces similar to those 
involved in protein folding. CDs may interact with proteins 
via hydrophobic forces, hydrogen bonding and Van der 
Waals interactions. Charged chemically modified CDs 
can also bind to the folding polypeptide chain via 
electrostatic interactions. CDs have been investigated in 
both dilution additive and artificial chaperone assisted 
modes. CDs have been used as stripping agents for the 
removal of detergents in proteins refolded with 
surfactants (Bajorunaite et al., 2009; Loretta and Ajit, 
2001). CDs have been used for refolding of recombinant-
human growth hormone (Yazdanparast et al., 2007) and 
 amylase (Yazdanparast et al., 2005). 
POLYETHYLENE GLYCOL (PEG) 
 
Polyethylene glycol is one of the water-soluble polymers 
that are used for refolding of recombinant proteins (Lee 
and Lee, 1987). PEG, a polyhydric alcohol, like other 
polyols are known to stabilize protein conformations as 
well as to increase the rate of in vitro protein refolding 
(Sato et al., 1996; Sawanoa et al., 1992).  
It enhances the recovery of active protein by preventing 
aggregation during refolding (Cleland and Wang, 1990). 
PEG improves in vitro structure formation, which can 
block aggregation by combining with a molten globule 
folding intermediate. It stabilizes proteins by chemical 
modification (Harris and Kozlowski, 2001; Roberts et al., 
2002). PEG binds an intermediate in the folding pathway 
of carbonic anhydrase, therefore prevent self-association 
and promote correct refolding (Cleland and Wang, 1990; 
Cleland et al., 1992). PEG interacts with the hydrophobic 
side chains exposed upon unfolding at high temperatures 
(Zielenkiewicz et al., 2006). PEG has been successfully 
used for refolding of interferon (Wang et al., 2006), 
xylanase (Rahimpour et al., 2007) and insulin like growth 
factor (IGF-1) (Hart et al., 1994) from inclusion bodies. 
 
 
AMMONIUM SULFATE ((NH4)2SO4) 
 
Salts can stabilize proteins through nonspecific 
electrostatic interactions at low concentration depending 
on the ionic strength of the medium (Tanford, 1961). At 
high concentrations, salts exert specific effects on 
proteins depending on the type and concentration of the 
salts, resulting in either the stabilization or destabilization 
of proteins, or even denaturation. Salts usually increase 
interfacial tension between the protein surface and 
solvent (Jarvis and Scheiman, 1968) that leads to 
incease in the solubility of proteins and aggregates. 




Although, the stabilizing effect of salts on protein 
structure is closely correlated to the salting-out effect of 
salts.  
Ammonium sulfate is widely used as a precipitant for 
protein purification and for crystallization as this salt can 
prevent aggregation. Ammonium salts have been 
reported to prevent heat-induced aggregation of 
lysozyme (Hirano et al., 2007). Also magnesium chloride 
is another example of salts that has been used in the 
refolding of recombinant proteins (Richter et al., 2002). 
 
 
PROLINE (PRO)  
 
The role of proline was studied for the first time in in vitro 
refolding of bovine carbonic anhydrase. Proline inhibited 
bovine carbonic anhydrase aggregation and enabled the 
protein to return to its native structure. It was proposed 
that proline acts as a protein-folding chaperone due to 
the formation of an ordered, amphipathic supramolecular 
assembly (Samuel et al., 2000). Later, proline was found 
to prevent aggregation during hen egg-white lysozyme 
refolding. Also, proline has been used during refolding of 
arginine kinase (Xia et al., 2007) and aminoacylase (Kim 
et al., 2006). Proline inhibits protein aggregation by 
binding to folding intermediates. Proline (1M) was also 
found to act as a creatin kinase (CK) folding aid (Meng et 
al., 2001). Results further indicate that proline possibly 
binds to and stabilizes folding intermediates and reduces 
the hydrophobic surface of CK, thus inhibiting protein 
aggregation and improving the final yield of CK. The 
unusual properties of proline may be due to hydrophobic 
stacking in aqueous solution and inter-molecular self-
association (Rudolph and Crowe, 1985). The 
hydrophobic nature of proline covers hydrophobic region 
of the proteins, through which this amino acid effectively 






Polyols vary in the length of carbon chain and number of 
hydroxyl groups. Polyols are used as additives for 
enhancing refolding yield and stabilizing protein structure. 
The structure-stabilizing polyols are supposed to lead to 
compact folded state. It was demonstrated that the 
addition of certain osmolytes results in the compaction of 
RNase A (Bolen and Baskakov, 2001). Polyols have 
been shown to stabilize the acid-unfolded molten globule 
state of cytochrome c by enhancing hydrophobic 
interactions that overcome electrostatic repulsion at low 
pH between charged residues (Kamiyama et al., 1999). 
Glycerol has long been known as a protein stabilizer, 
and its stabilization mechanism has been shown by 
Timasheff (2002). Glycerol leads to the enhancement of 





solvent ordering around proteins. Compared with the 
other polyols, glycerol is a mild stabilizer of protein 
conformation. Unlike other polyols, glycerol has unusual 
properties that decreases the surface tension of water but 
increases its viscosity (Gekko and Timasheff, 1981). 
Increasing glycerol concentrations is known to increase 
the stability of proteins at all concentrations (Jain and 
Ahluwalia, 1997; Timasheff, 2002) although, it decreases 
refolding at high concentrations due to its ability to 
considerably slow down the kinetics of refolding, which 
could result in off-pathway aggregation. An optimum 
glycerol concentration seems to be critical for striking a 
balance between its stabilizing effect governed by 
thermodynamic principles and its effect on the kinetics of 
folding. Glycerol is successfully used in refolding of 
lysozyme (Cao et al., 2002). 
Sorbitol is another polyol that has been shown to 
reduce aggregation of nucleocapsid protein of 
rhabdovirus after its expression in Escherichia coli 
(Majumder et al., 2001). Sorbitol is likely to exert its effect 
on folding by altering the structure and properties of 
water around the folding protein molecule. Erythritol is 
also a protein structure stabilizer and studies showed that 
it stabilizes proteins to a lesser extents when compared 
with sorbitol (Gekko and Morikawa, 1981). The study on 
citrate synthase aggregation kinetics during refolding in 
erythritol and other polyols showed the ability of the 
polyols to stabilize proteins depending on the number of 





Obtaining a good amount of active protein at low cost is 
the main objective in the in vitro refolding of recombinant 
proteins from bacterial inclusion bodies, but there is no 
single refolding technique or method that satisfies all 
protein refolding processes. With providing a good 
condition for in vitro refolding, bacterial system could be 
an excellent alternative to the mammalian expression 
system or other expression systems that can directly 
generate active proteins with a complex disulfide bond 
structures. In this process, the solubilized target protein is 
subjected to refolding using different methods. Low 
molecular weight additives are helpful agents for 
increasing protein concentration, especially in dilution 
method. Therefore, application and optimization of 
different additives and their concentration is a main step 
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